Workflow
PTC(PTC)
icon
Search documents
PTC's Q1 Earnings & Revenues Top Estimates, Up Y/Y on Market Strength
ZACKS· 2025-02-06 15:05
Core Insights - PTC Inc reported first-quarter fiscal 2025 non-GAAP EPS of $1.10, exceeding the Zacks Consensus Estimate by 20.9% and showing a slight decrease from $1.11 in the prior-year quarter [1] - Revenues reached $565 million, reflecting a 3% year-over-year increase, and surpassed the consensus estimate by 2.4%, driven by strong demand for PLM and CAD solutions [2] Financial Performance - Recurring revenues amounted to $524.3 million, up 3.6% year over year, while perpetual licenses increased by 11.4% to $9.4 million [4] - License revenues constituted 30.6% of total revenues at $172.8 million, down 6.1% year over year, whereas support and cloud services revenues (63.9%) rose 9.2% to $361 million [5] - PLM revenues were $353 million, up 1% year over year, and CAD revenues were $212 million, up 5% year over year [6] ARR and Growth Metrics - Annualized recurring revenues (ARR) reached $2.205 billion, a 7% increase year over year, with a constant currency ARR of $2.277 billion, up 11% [7] - In the fiscal first quarter, PLM and CAD ARR were $1,357 million and $848 million, rising 8% and 5% year over year, respectively [7] Operating Metrics - Non-GAAP gross margin remained stable at 82.7%, while total operating expenses increased by $17 million year over year to $338 million [8] - Operating income on a non-GAAP basis fell 4% year over year to $191 million, but operating margin improved by 240 basis points to 34% [8] Balance Sheet and Cash Flow - As of December 31, 2024, cash and cash equivalents were $196 million, down from $266 million as of September 30, 2024, while total debt decreased to $1.544 billion [10] - Cash provided by operating activities was $238 million, compared to $187 million in the prior-year quarter, and free cash flow increased to $236 million from $183 million [10] Financial Outlook - For the second quarter of fiscal 2025, PTC estimates revenues between $590 million and $620 million, with non-GAAP EPS projected in the range of $1.30 to $1.50 [11] - Full fiscal 2025 revenues are now projected between $2,430 million and $2,530 million, indicating a 6-10% year-over-year rise, with non-GAAP EPS estimated at $5.30 to $6.00 [12] - Cash from operations is expected to be between $850 million and $865 million, reflecting a 13% to 15% year-over-year increase [13]
PTC(PTC) - 2025 Q1 - Earnings Call Transcript
2025-02-06 03:50
PTC Inc. (NASDAQ:PTC) Q1 2025 Earnings Conference Call February 5, 2025 5:00 PM ET Company Participants Matt Shimao - Head of Investor Relations Neil Barua - President and Chief Executive Officer Kristian Talvitie - Chief Financial Officer Conference Call Participants Jay Vleeschhouwer - Griffin Securities, Inc. Jason Celino - KeyBanc Capital Markets Inc. Ken Wong - Oppenheimer & Co. Inc. Siti Panigrahi - Mizuho Securities Co., Ltd. Stephen Tusa - JPMorgan Chase & Co. Arsenije Matovic - Wolfe Research, LLC ...
PTC Inc. (PTC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-02-05 23:30
Core Insights - PTC Inc. reported revenue of $565.13 million for the quarter ended December 2024, reflecting a year-over-year increase of 2.7% [1] - The company's EPS was $1.10, slightly down from $1.11 in the same quarter last year, but exceeded the consensus estimate of $0.91 by 20.88% [1] - The reported revenue surpassed the Zacks Consensus Estimate of $551.92 million, resulting in a surprise of 2.39% [1] Financial Performance Metrics - Annual Recurring Revenue (ARR) was reported at $2.21 billion, below the three-analyst average estimate of $2.28 billion [4] - Recurring Revenue reached $524.31 million, exceeding the four-analyst average estimate of $515.94 million, with a year-over-year increase of 3.6% [4] - Professional Services revenue was $31.41 million, slightly above the four-analyst average estimate of $31.14 million, but showed a year-over-year decline of 12.1% [4] - Perpetual License revenue was reported at $9.41 million, significantly above the four-analyst average estimate of $6.76 million, marking an 11.4% year-over-year increase [4] Stock Performance - PTC Inc. shares have returned 4.4% over the past month, outperforming the Zacks S&P 500 composite's 1.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]
PTC Inc. (PTC) Tops Q1 Earnings and Revenue Estimates
ZACKS· 2025-02-05 23:10
PTC Inc. (PTC) came out with quarterly earnings of $1.10 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $1.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 20.88%. A quarter ago, it was expected that this product development software maker would post earnings of $1.43 per share when it actually produced earnings of $1.54, delivering a surprise of 7.69%.Over the last four quar ...
PTC(PTC) - 2025 Q1 - Quarterly Results
2025-02-05 21:01
EX 99.1 PTC ANNOUNCES FIRST FISCAL QUARTER 2025 RESULTS First Fiscal Quarter 2025 Highlights Key operating and financial highlights are set forth below. The definitions of our operating and non-GAAP financial measures and reconciliations of non-GAAP financial measures to comparable GAAP measures are included below and in the reconciliation tables at the end of this press release. | $ in millions | Q1'25 | Q1'24 | YoY Change | Q1'25 Guidance | | --- | --- | --- | --- | --- | | ARR as reported | $2,205 | $2,0 ...
PTC ANNOUNCES FIRST FISCAL QUARTER 2025 RESULTS
Prnewswire· 2025-02-05 21:01
Solid ARR and Cash FlowBOSTON, Feb. 5, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today reported financial results for its first fiscal quarter ended December 31, 2024."In Q1'25, we delivered solid year-over-year constant currency ARR growth of 11% and cash flow growth above 25%, which was in-line with our guidance. Our differentiated strategy leverages our unique portfolio to help product companies accelerate their time to market and manage increasing complexity. It's an exciting time because our products are ...
Countdown to PTC Inc. (PTC) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
ZACKS· 2025-02-04 15:20
Wall Street analysts expect PTC Inc. (PTC) to post quarterly earnings of $0.91 per share in its upcoming report, which indicates a year-over-year decline of 18%. Revenues are expected to be $551.92 million, up 0.3% from the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Ahead of a company's earnings disclosure, it is crucial to give d ...
PTC to Report Q1 Earnings: Here's What Investors Should Know
ZACKS· 2025-02-03 14:45
PTC Inc (PTC) is scheduled to report first-quarter fiscal 2025 results on Feb. 5.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.For the quarter, PTC anticipates revenues between $540 million and $570 million. Non-GAAP EPS is expected in the range of 75 cents to 95 cents.The Zacks Consensus Estimate for revenues is pegged at $551.9 million, indicating an increase of 0.3% from the year-ago reported number. The consensus estimate for earnings is pegged at 91 cents per share, down 18% ...
PTC to Announce Fiscal Q1'25 Results on Wednesday, February 5th, 2025
Prnewswire· 2025-01-15 14:49
BOSTON, Jan. 15, 2025 /PRNewswire/ -- PTC (Nasdaq: PTC) will release its fiscal 2025 first quarter results on Wednesday, February 5th after the stock market closes. Senior management will host a live webcast and conference call to review the results on Wednesday, February 5th at 5 pm Eastern Time. The earnings press release, accompanying earnings presentation, and financial data tables will be accessible prior to the conference call and webcast on the Investor Relations section of the Company's website at P ...
PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference
Prnewswire· 2025-01-13 14:00
– Unaudited 2024 total revenue of approximately $814 million, exceeding guidance –– Four approval applications submitted to FDA in 2024 –– Global launch preparations underway for sepiapterin for PKU, a $1 billion market opportunity; CHMP opinion expected Q2 2025, U.S. approval decision in July 2025 –  – License and collaboration agreement with Novartis for PTC518 program closed – – PIVOT-HD data readout for PTC518 expected Q2 2025 –WARREN, N.J., Jan. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: ...